Pregnancy complicated by the antiphospholipid syndrome: Outcomes with intravenous immunoglobulin therapy

Obstetrics and Gynecology

Volumn 93, Issue 3, 1999, Pages 437-441

  Clark, Ann L ^a,b,c   Branch, D Ware ^a,b,c   Silver, Robert M ^a,b,c   Harris, E Nigel ^a,b,c   Pierangeli, Silvia ^a,b,c   Spinnato, Joseph A ^a,b,c  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; IMMUNOGLOBULIN; STEROID;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL ARTICLE; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; OUTCOMES RESEARCH; PREGNANCY COMPLICATION; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; STEROID THERAPY; TREATMENT OUTCOME;

EID: 0033104286     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(98)00437-2     Document Type: Article

References (24)

1. Harris E.N. Syndrome of the black swan. Br J Rheumatol. 26:1987;324-326.
2. Branch D.W., Silver R.M., Blackwell J.L., Reading J.C., Scott J.R. Outcome of treated pregnancies in women with antiphospholipid syndrome An update of the Utah experience . Obstet Gynecol. 4:1992;614-620.
3. Branch D.W., Dudley D.J., Mitchell M.D., Creighton K.A., Abbott T.M., Hammond E.H., et al. Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in Balb/c mice A model for autoimmune fetal loss . Am J Obstet Gynecol. 163:1990;210-216.
4. Cowchock F.S., Reece E.A., Balaban D., Branch D.W., Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies A collaborative randomized trial comparing prednisone to low-dose heparin treatment . Am J Obstet Gynecol. 166:1992;1318-1323.
5. Rosove M.H., Tabsh K., Wasserstrum N., Howard P., Hahn B.H., Kalumian K.C. Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies. Obstet Gynecol. 75:1990;630-634.
6. Dahlman T. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol. 168:1993;1265-1270.
7. Lima F., Khamashta M.A., Buchanan N.M.M., Kerslake S., Hunt B.J., Hughes G.R.V. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol. 14:1996;131-136.
8. Francois A., Freund M., Daffos F., Remy P., Aiach M., Jacquot C. Repeated fetal losses and the lupus anticoagulant. Ann Intern Med. 109:1988;993-994.
9. Scott J.R., Branch D.W., Kochenour N.K., Ward K. Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization. Am J Obstet Gynecol. 159:1988;1055-1056.
10. Parks A., Maier D., Wilson D., Andresli J., Ballow M. Intravenous gamma globulin, antiphospholipid antibodies and pregnancy. Ann Intern Med. 110:1989;495-496.
11. Wapner R.J., Cowchock F.S., Shapiro S.S. Successful treatment in two women with antiphospholipid antibodies and refractory pregnancy losses with intravenous immunoglobulin infusions. Am J Obstet Gynecol. 161:1989;1271-1272.
12. Spinnato J.A., Clark A.L., Pierangeli S.S., Harris E.N. Intravenous immunoglobulin therapy for the antiphospholipid syndrome in pregnancy. Am J Obstet Gynecol. 172:1995;690-694.
13. Harris E.N. Annotation Antiphospholipid antibodies . Br J Haematol. 74:1990;1-9.
14. Harris E.N. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Antiphospholipid Antibody Study (KAPS) group. Am J Clin Pathol. 94:1990;476-484.
15. Triplett D.A., Brandt J.T., Kaczor D., Schaeffer J. Laboratory diagnosis of lupus inhibitors A comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure . Am J Clin Pathol. 79:1983;678-682.
16. American College of Obstetricians and Gynecologists. Management of preeclampsia. ACOG technical bulletin no. 91. Washington DC: American College of Obstetricians and Gynecologists, 1986.
17. Usher R., McLean F. Intrauterine growth of live born caucasian infants at sea level. J Pediatr. 74:1969;901-910.
18. Valensise H., Vaquero E., De Carolis C., Stipa E., Perrigone R., Arduinis D., et al. Normal fetal growth in women with antiphospholipid syndrome treated with high-dose intravenous immunoglobulin (IVIG). Prenat Diagn. 15:1995;509-517.
19. ASHP Commission on Therapeutics . ASHP therapeutic guidelines for intravenous immune globulin. Clin Pharm. 11:1992;117-136.
20. Arnout J., Spitz B., Wittevrongel C., Vanrusselt M., Van Assche A., Vermylen J. High-dose intravenous immunoglobulin treatment of a pregnant patient with an antiphospholipid syndrome Immunological changes associated with a successful outcome . Thromb Haemost. 71:1994;741-747.
21. Anderson C.L. Human IgG fc receptors. Clin Immunol Immunopathol. 53:1989;563-571.
22. Arvieux J., Roussel B., Pouzol P., Columb M.G. Platelet activating properties of murine monoclonal antibodies to beta 2-glycoprotein I. Thromb Haemost. 70:1993;336-341.
23. Arnout J. The pathogenesis of the antiphospholipid syndrome A hypothesis based on parallelisms with heparin-induced thrombocytopenia . Thromb Haemost. 75:1996;536-541.
24. Bakimer R., Guilburd B., Zurgil N., Shoenfeld Y. The effect of intravenous gamma-globulin on the induction of experimental antiphospholipid syndrome. Clin Immunol Immunopathol. 69:1993;97-102.